DIRD+ is an open-source desktop application that detects signs of diabetic retinopathy with local AI. No cloud, no per-screening fee — patient data never leaves the device.
Diabetic retinopathy is the leading cause of blindness in working-age adults — and over 80% of it is preventable with timely screening. DIRD+ brings AI screening to clinics that lack specialists, budget, or stable internet.
All AI inference runs on the device. Zero transmission to external servers. The database is encrypted at rest (AES-256).
After a one-time model download, everything runs locally. Built for areas with no reliable connectivity.
No licenses, no per-screening fee, no proprietary hardware. Works with any existing fundus camera.
Plug in your own ONNX model via a simple model card — calibrated to your own population, no code changes.
Clinical guidelines are JSON files. Ships with ICDR 2024 and MINSAL Chile 2017; add new ones without coding.
Fully auditable under GNU AGPLv3. Algorithms, thresholds and criteria are transparent and verifiable.
A deterministic, auditable pipeline. The clinical guideline makes the decision; the optional local LLM only writes the prose.
Load fundus images (OD/OI) from any camera into the desktop app.
Local ONNX models find lesions (hemorrhages, exudates, edema, microaneurysms…).
Inspect, correct and annotate on a multi-layer canvas with measurement tools.
The pluggable guideline grades severity with treatment and follow-up — deterministic, no black box.
A configurable PDF; an optional in-process LLM polishes the prose, never the decision.
Portable, encrypted .dird containers move data between installations.
Train on your own cohort and deploy inside DIRD+ — no vendor lock-in.
[1,3,640,640]Adapt classification to any national protocol — guidelines are data, not code.
DIRD+ aligns with the Digital Public Goods Standard: open licensing, clear ownership, platform independence, privacy by design, and open standards (ONNX, PDF, SQLite, JSON, AES-256, Argon2id).